Overview
Status
Active
Registry date
2023-08-08
Share capital
5,000.00 PLN
Registered address
ul. Dolna 102, 15-697 Białystok, Poland
Financials
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 202402/07/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles20,280 / 42,239
Top 48%
Voivodeship · Podlaskie2,992 / 9,020
Top 33%
Country · Poland149,082 / 495,850
Top 30%
Results vs industry
Revenue
This companyUSD 683.97kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 31.57kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 646.49kMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 524.49kMedianUSD 609.81kAverageUSD 11.84m
Industry
Authorized Representatives
Żana Trusewicz – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Vitali Heniukage 46 | 50 | $675.31 | 50% |
Stanisław Trusewiczage 58 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-09-01.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A. | $146,864,520.79 | multipharme.pl | ||
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | ||
| Cirrosp. z o.o. | $20,863,166.14 | cirro.pl | ||
| Premmier Redsp. z o.o. | $2,723,178.99 | premmier.com | ||
| Lock Pharmasp. z o.o. | $737,058.47 | lockpharma.pl | ||
| Goldfarmexsp. z o.o. | $710,510.28 | goldfarmex.pl | ||
| Interforum Pharmasp. z o.o. | $710,214.55 | interforumpharma.com | ||
| Grupa Arnet-Profsp. z o.o. | $619,697.70 | arnetprof.eu | ||
| Orthoactivesp. z o.o. | $617,449.08 | orthoactive.pl | ||
| Temedasp. z o.o. | – | temeda.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-03-26 | Business resumed | |
| 2024-03-25 | Business suspended | |
| 2023-08-08 | Entered in the register |
FAQ
The main business activity of Stavita focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on August 8, 2023.
The headquarters is located at: ul. Dolna 102, 15-697 Białystok.
The management board consists of: Żana Trusewicz (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from August 8, 2023 to December 31, 2024.
The company reported a revenue of $683,969 in 2024.
Yes, in 2024 the company achieved a net profit of $31,573.
The largest operating cost category falls under materials and energy. This category amounted to $644,117 in 2024, representing 100% of all operating expenses.
Last updated: 2026-03-27